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Abstract
Background: While the pneumococcal protein conjugate vaccines reduce the incidence in invasive pneumococcal disease
(IPD), serotype replacement remains a major concern. Thus, serotype-independent protection with vaccines targeting
virulence genes, such as PspA, have been pursued. PspA is comprised of diverse clades that arose through recombination.
Therefore, multi-locus sequence typing (MLST)-defined clones could conceivably include strains from multiple PspA clades.
As a result, a method is needed which can both monitor the long-term epidemiology of the pneumococcus among a large
number of isolates, and analyze vaccine-candidate genes, such as pspA, for mutations and recombination events that could
result in ‘vaccine escape’ strains.
Methodology: We developed a resequencing array consisting of five conserved and six variable genes to characterize 72
pneumococcal strains. The phylogenetic analysis of the 11 concatenated genes was performed with the MrBayes program,
the single nucleotide polymorphism (SNP) analysis with the DNA Sequence Polymorphism program (DnaSP), and the
recombination event analysis with the recombination detection package (RDP).
Results: The phylogenetic analysis correlated with MLST, and identified clonal strains with unique PspA clades. The DnaSP
analysis correlated with the serotype-specific diversity detected using MLST. Serotypes associated with more than one ST
complex had a larger degree of sequence polymorphism than a serotype associated with one ST complex. The RDP analysis
confirmed the high frequency of recombination events in the pspA gene.
Conclusions: The phylogenetic tree correlated with MLST, and detected multiple PspA clades among clonal strains. The
genetic diversity of the strains and the frequency of recombination events in the mosaic gene, pspA were accurately
assessed using the DnaSP and RDP programs, respectively. These data provide proof-of-concept that resequencing arrays
could play an important role within research and clinical laboratories in both monitoring the molecular epidemiology of the
pneumococcus and detecting ‘vaccine escape’ strains among vaccine-candidate genes.
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Introduction
Streptococcus pneumoniae, a causative agent of pneumonia,
meningitis, otitis media and bacteremia causes significant
morbidity and mortality worldwide. Young children, the elderly
population and immunocompromised individuals are at the highest
risk of pneumococcal diseases. S. pneumoniae is also the predom-
inant pathogen in community-acquired pneumonia [1] and is
associated with substantial health care cost in adults [2]. The 23-
valent pneumococcal polysaccharide vaccine (PPV23) provides
significant serotype-specific protection against invasive disease in
adults; however, rates of invasive pneumococcal disease (IPD) were
still substantial. Fortunately, the introduction of the 7-valent
pneumococcal protein conjugate vaccine (PCV7) in 2000, which
includes serotypes 4, 6B, 9V, 14, 18C, 19F and 23F, led to
significant decline in invasive pneumococcal disease in children
and adults through receipt of the vaccine and herd immunity,
respectively [2,3].
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of PCV7 in high-risk populations [4,5]. In children, the incidence
of non-PCV7 serotype 3 invasive disease is significantly increasing
[6], and has been associated with increased morbidity among
patients with pneumococcal pneumonia [7]. Moreover, serotype 3
strains have caused an increasing proportion of cases of otitis
media in the PCV7 era [8]. The recent licensure of PCV13 [9],
which includes PCV7 serotypes plus serotypes 1, 3, 5, 6A, 7F and
19A will likely decrease serotype 3 disease; however, non-PCV13
serotypes may likely be associated with serotype replacement in
the future.
Serotype replacement can occur due to the expansion of
existing clones, emergence of new clones, or serotype capsular
transformation with strains with PCV7 serotypes. Multilocus
sequence typing (MLST) is a standard molecular subtyping
technique which can ascertain the genetic relatedness between
strains [10]. A clone can be defined as sharing 5 of 7 housekeeping
gene alleles, or belonging to the same sequence type (ST)-complex.
Strains which belong to the same ST-complex but have different
serotypes are commonly classified as strains that have undergone
capsular transformation. To illustrate, the serotype 3 strains
associated with an increasing percentage of otitis media in the
PCV7 era all belong to ST180-complex [8], suggesting the
expansion of a non-PCV7 clone. Likewise, non-PCV7 serotype
19A disease has dramatically increased in the United States in the
PCV7 era, and most of the penicillin-resistant serotype 19A strains
appear to have arisen through capsular transformation with the
Taiwan
19F-14 clone [11]. In both scenarios clonal expansion
occurred, reinforcing the theory that a few clones cause a
disproportionate amount of pneumococcal disease.
While MLST and serotyping analysis can quickly ascertain
strains which have undergone recombination at the capsular locus,
additional methods are needed to determine the frequency of
SNPs, recombination, and deletions in virulence genes. Under-
standing the role of recombination and polymorphism in the
genetic diversity of an organism, bacterial evolution and emerging
pathogens is vital in developing therapeutic or vaccine strategies
for a disease [12]. Recombination-mediated genome plasticity is
considered to be a strategy for adapting to environmental changes
for S. pneumoniae and represents a mechanism for rapid evolution of
the genome [13] leading to emergence of new genotypes with
altered or novel phenotypes [14]. This can have a considerable
impact on bacterial evolution and human health. Recombination
in house-keeping and virulence genes has been reported in group
B Streptococcus (GBS) as a factor contributing towards genomic
diversity between genotypes and for distinct disease pathogenesis
of strains [15]. Inter and intra-species recombination in S. oralis has
also been suggested [16].
Pneumococcal genomics has accelerated whole genome com-
parative analysis of strains and have led to identification of
a core set of essential genes, genes contributing to virulence
and genes involved in maintaining a non-invasive phenotype
[17,18,19,20,21]. Despite the decreasing cost of complete genome
sequencing, this method is cost-prohibitive given that thousands of
clinical isolates will need to be sequenced for epidemiologic
purposes. Moreover, the software analysis programs cannot
determine the significance of each mutation detected As a result,
the development of multi-virulence-locus sequence typing
(MVLST) scheme has been reported. This method was found to
be more suitable for local epidemiology, providing higher level of
discrimination for Listeria monocytogenes compared to MLST based
on housekeeping genes of this species [22]. An alternative to
MLST is also needed for S. pneumoniae. For example, strains
belonging to the same ST or serotype have been shown to differ
genetically and phenotypically in an animal model of infection
[23]. Moreover, recent studies indicate that a repertoire of
accessory regions can differ even among isolates of the same
clone [24]. However, MVLST may not be feasible for S.
pneumoniae, given that up to 10% genome variation exists between
S. pneumoniae strains [25].
In this study, we developed a targeted Affymetrix, Inc.
GeneChipH resequencing approach based on a single TIGR4
reference genome supplemented with Sanger sequencing to
determine whether this method correlated with MLST, and
whether it could provide further discrimination among highly-
related strains. We also sought to determine whether nucleotide-
level diversity, recombinations, and deletions could be detected
among 72 pneumococcal strains. The five conserved gene
sequences include 16S rRNA, DNA-directed RNA polymerase
and three hemolysin gene fragments. The 16S rRNA and DNA-
directed RNA polymerase are not only conserved sequences but
also important housekeeping markers. Both are stable phyloge-
netic markers widely used in bacterial phylogenetics due to
reduced frequency of heterologous gene exchanges [26,27].
Furthermore, the gene encoding the highly conserved subunit of
the bacterial RNA polymerase, has been used to identify
streptococcus species of medical interest [28,29]. Hemolysins are
pore-forming exotoxin proteins that cause in vitro lysis of red blood
cells. In S. pneumoniae, these major virulence proteins have been
renamed pneumolysins due to their ability to lyse any eukaryotic
cell containing cholesterol in its membrane [30]. The hemolysin
and hemolysin-related sequences are relatively conserved in S.
pneumoniae compared to other virulence factors.
The six variable gene sequences encode a portion of four cell
wall surface anchor proteins and two pneumococcal surface
proteins. Surface proteins play a vital role in the infectious process
of pathogenic bacteria and are known to significantly contribute to
virulence [31]. Pneumococcal surface protein A (pspA), a mosaic
gene which has evolved through extensive recombination, is a
vaccine candidate [32,33]. Specifically, PspA interferes with the
fixation of complement C3 [34] and binds human lactoferrin [35].
PspA attaches to the pneumococcal cell surface at its C-terminus
by binding its conserved choline-binding domain to the choline in
the membrane-associated lipoteichoic acid [35]. The proline-rich
region is adjacent to the choline-binding domain, and is likely cell
wall associated. In contrast, the N-terminal alpha-helical coil,
which includes the clade-defining region, is exposed. The clade-
defining region, determined by residues 192–290, is markedly
diverse. A classification has been adopted that divides PspA
molecules into three families and six clades: family 1 includes
clades 1 and 2, family 2 includes clades 3,4, and 5, and family 3
includes clade 6 [32]. While PspA clade designation is not
associated with serotype, a single clone usually consists of strains
from one specific PspA clade [36].
Most of the immunization studies target the clade-defining
region within the N-terminal alpha-helical coil on the pneumo-
coccal cell surface, since these epitopes are highly antibody
accessible. While vaccines which target a specific clade can provide
cross-protection against strains from different clades [37,38], the
highest degree of protection is detected when the challenge strain
is from the same clade [39,40]. Recently, immunization with
conserved recombinant proline-rich region of PspA has been
demonstrated to provide protection against infection due to strains
from different PspA clades [41].
In an effort to ascertain the genetic relatedness of these strains,
we developed a resequencing array of five conserved and six
variable sequences. In this array, the vaccine candidate evaluated
was PspA; however, other arrays could include other variable
Pneumococcal Resequencing Array
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would be $90% among conserved sequences, and $50% among
variable sequences. We also hypothesized that the phylogenetic
analysis of the 11 concatenated gene sequences would both
correlate with MLST as well as provide further discrimination
between strains. Furthermore, we anticipated that the array would
provide proof-of-concept that the DNA Sequence Polymorphism
program (DnaSP) and the recombination detection program
(RDP) could accurately detect SNPs, large mutations, and
recombination events among these strains. If successful in this
study, we anticipate that resequencing arrays could both monitor
the epidemiology of the pneumococcus as well as monitor for
‘vaccine escape’ strains among vaccine-candidate genes.
Materials and Methods
Genomic DNA of S. pneumoniae strains analyzed in this study are
shown in Table S1. The strains included the reference strain
TIGR4, sequenced strains R6, 670 and G54, the first 25
international pneumococcal clones (www.sph.emory.edu/pmen)
[42], and 43 strains that caused acute otitis media in children [8].
The dataset included strains from 24 known serotypes/serogroups
and 38 different ST-complexes. The strains isolated from children
with acute otitis media included genetically related serotype 3
strains, genetically diverse strains belonging to a medley of
different serotypes/serogroups and ST-complexes, and genetically
related strains which appeared to have undergone capsular
transformation (Tables 1 and 2). Given the limitation of the
software used to generate the figures, the clones, the Spanish 23F
clone, will be referenced as Spain
23F-1 or 23F-1. Genomic DNA
was isolated from the strains with Qiagen DNeasy Blood & Tissue
Kit (Valencia, CA) and stored at -80uC.
Design of S. pneumoniae Custom Resequencing Array
Fully sequenced and completely annotated S. pneumoniae TIGR4
sequence (GenBank Accession: AE005672) [43] was used as a
reference genome to design a 30 Kb CustomSeq resequencing
chip. Both the strands of the selected 11 non-contiguous genomic
regions were tiled on the array representing ,0.5 to 5.3 Kb of
fragment size for a total of 20,169 bases (Table 3). A single S.
pneumoniae resequencing chip with a standard array format of
12.8 mm and feature size of 20625 micron design capable of
resequencing a maximum of 29,375 bases was fabricated by
Affymetrix, Inc. (Santa Clara, CA). A total of 20,169 bp of non-
contiguous reference array sequence would provide resequencing
coverage of 19,905 bases, corresponding to 0.933% of pneumo-
coccal genome information.
Targeted-genome Resequencing Assay
S. pneumoniae genomic DNA amplification, DNA fragmentation,
labeling, hybridization and acquisition of raw data was carried out
as described earlier [44] with minor modifications for 30K
resequencing array. Briefly, 2 mg of genomiphied DNA per chip
was fragmented in a 50 ml reaction containing 2 ml of fragmen-
tation reagent (0.15U/ml, Affymetrix, Inc., Santa Clara, CA) for
20 minutes at 37uC for the resequencing assay and chips were
washed and stained on the GeneChipH fluidics station 450 using
the pre-programmed DNA Array_WS2 wash protocol and
scanned with GeneChipH Scanner 3000 (Affymetrix, Inc., Santa
Clara, CA). The Affymetrix GenechipH DNA Analysis Software
(GDAS) Version 3.0.1 with default resequencing algorithm settings
for haploid model system was used to analyze hybridization results
and obtain raw data. The raw data was processed with our
bioinformatic filters. These bioinformatic filters consists of Perl
scripts that operate on the CHP files generated by GDAS software
and produce a list of high-confidence sequence and SNP calls from
a larger raw data set present in those files [44,45]. These scripts
are available for download from our website http://pfgrc.jcvi.org/
index.php/compare_genomics/snp_scripts.html.
Table 1. ST-complex and serotype/serogroup designation of
72 pneumococcal strains.
ST complex
Total number of
strains/ST-complex
Serotype/Serogroup
(no. strains)
ST81 5 23F (2), 19F (2), 23B (1)
ST180 18 3 (18)
ST199 3 19A (2), 15 (1)
ST377 4 35B (1), 35 (1), 6B (1), 14 (1)
ST690 3 6A (1), 19A (1), NT (1)
ST9 1 14 (1)
ST18 1 14 (1)
ST20 1 14 (1)
ST37 1 23F(1)
ST41 1 19A (1)
ST62 1 11 (1)
ST63 1 15A (1)
ST67 1 14 (1)
ST75 1 19A (1)
ST90 2 6B (2)
ST113 1 18C (1)
ST156 2 9V (2)
ST173 1 23F (1)
ST175 1 19A (1)
ST177 1 19F (1)
ST185 1 6B (1)
ST205 1 4 (1)
ST227 1 1 (1)
ST236 1 19F (1)
ST242 1 23F (1)
ST268 1 19A (1)
ST270 1 6B (1)
ST289 1 5 (1)
ST315 1 6B (1)
ST376 1 6A (1)
ST384 1 6B (1)
ST393 1 38 (1)
ST433 1 22 (1)
ST498 1 35 (1)
ST659 1 16 (1)
ST816 1 10 (1)
ST1201 1 7 (1)
ST1257 1 20 (1)
TIGR4 1 4 (1)
R6 1 2 (1)
G54 1 19F (1)
670 1 6B (1)
doi:10.1371/journal.pone.0015950.t001
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The pneumococcal genome plasticity and inherent limitation of
sequencing by hybridization approach resulted in ‘no calls’ on
resequencing platform in several pneumococcal strains, especially
in rapidly evolving variable gene sequences. In such cases we used
ABI Sanger Bigdye terminator sequencing chemistry to expand
the coverage of the genomic information obtained from resequen-
cing platform. Sequences obtained from the same regions of
multiple strains on resequencing arrays were used to design gene-
specific sequencing primers for the genomic fragments. The
template DNA from various pneumococcal strains required for
ABI sequencing was PCR amplified using end-primers designed
using the corresponding TIGR4 reference sequence. Primers
(Table S2) were designed using Primer3 [46] and the sequencing
was done at the Joint Technology Center (http://www.jcvi.org/
cms/research/platforms/sequencing/) using high-throughput 1/
64 Big Dye terminator reaction protocol. Briefly, the sequencing
reactions performed in 384-well plate format contained 20 ng of
PCR amplified and purified gene product, 3.2 pmol of primer and
0.125 ml of Big dye terminator reagent in a total volume of 3 ml.
The thermal cycling parameters of 96uC for 2 min followed by 50
cycles of 96uC for 10 seconds and 60uC for 4 min were used. The
reaction plate was held at 10uC until loaded on 3730xl DNA
analyzer.
The individual ABI sequence reads for a given gene from each
strain were assembled de novo to form contigs using TIGR
Assembler [47]. Each of the contigs was aligned by nucmer
(http://mummer.sourceforge.net/manual/#nucmer) against the
homologous gene sequence from the reference TIGR4 strain to
obtain coordinates for the gene sequence of the strain selected in
our study. Similar nucmer alignment analysis was also carried out
for the sequence generated for the same gene on the resequencing
array platform and the reference sequence. The reference-
normalized coordinates from both the alignments were used to
mutually compare sequences obtained from ABI sequencing and
resequencing arrays. When sequences generated from both ABI
and resequencing array methods overlapped but differed in a base
call, the base with the better quality score (empirically derived ABI
and resequencing array Phred equivalent quality scores) was
chosen over the other. In cases where a base call was available
from only one of the two sequencing platforms, the base was
retained in the final sequence provided the Phred equivalent
Table 2. Serotype/Serogroup and ST-complex designation of
72 pneumococcal strains.
Serotype/
Serogroup ST-complexes (no. strains)
1 227 (1)
2 R6 strain
3 180 (18)
4 205 (1) & TIGR4 strain
5 289 (1)
6A 376 (1), 690 (1)
6B 90 (2), 185 (1), 270 (1), 315 (1), 377 (1), 384 (1) & 670 strain
7 1201 (1)
9V 156 (2)
10 816 (1)
11 62 (1)
14 9 (1), 18 (1), 20 (1), 67 (1), 377 (1)
15 199 (1)
15A 63 (1)
16 659 (1)
18C 113 (1)
19A 41 (1), 75 (1), 175 (1), 199 (2), 268 (1), 690 (1)
19F 81 (2), 177 (1), 236 (1) & G54 strain
20 1257 (1)
22 433 (1)
23B 81 (1)
23F 37 (1), 81 (2), 173 (1), 242 (1)
35 377 (1), 498 (1)
35B 377 (1)
38 393 (1)
NT 690 (1)
doi:10.1371/journal.pone.0015950.t002
Table 3. The eleven genomic fragments included on the TIGR4 resequencing chip
Gene Classification Name/Locus Gene/Sequence Length (bp) Sequenced length (bp)
Conserved 16S_rRNA 16S rRNA 1413 1389
SP_0834 Hemolysin-related protein 510 486
SP_1204 Hemolysin A - putative 594 570
SP_1466 Hemolysin 645 621
SP_1961 DNA-directed RNA polymerase – b subunit 3609 3585
Variable SP_0368 Cell wall surface anchor family protein 1 5301 5277
SP_1833 Cell wall surface anchor family protein 2 2124 2100
SP_1992 Cell wall surface anchor family protein 3 663 639
SP_2145 Antigen, cell wall surface anchor family 2082 2058
SP_0667 Pneumococcal surface protein - putative 996 972
SP_0117 Pneumococcal surface protein A 2232 2208
Total Bases 20169 19905
doi:10.1371/journal.pone.0015950.t003
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extending the length of the sequence coverage for the genes to
$95% (95% to 105%) when compared to the corresponding
TIGR4 sequences except for the eleven sequences listed in Table
S3 (1.4% of total sequences). All the sequences are available and
can be downloaded from our website http://pfgrc.jcvi.org/index.
php/compare_genomics/s_pneumo_data_release.html.
The final sequences were aligned by Muscle [48] and
alignments were used in the evaluation of the extent of sequence
variation, phylogenetic and recombination analyses. The DnaSP
software package, version 5.1 (http://www.ub.edu/dnasp/) [35]
was used to estimate DNA sequence variation parameters among
multi-aligned sequences (Table 4). This program can estimate
several measures of DNA sequence variation within and between
populations, including summary statistics for total number of
mutations, Eta (), the number of segregating polymorphic sites (S),
% GC; diversity parameters such as average pair wise nucleotide
difference per site [NucDiversity, p] [49], the average pair wise
nucleotide difference per sequence [AvNumDif, k] [50], and
thetaG (hG) - the mutation parameter per sequence [51]. The
statistics in each group are normalized for the total net number of
sites and expressed per 1000 bases as the number of strains and
gene sequences available for analysis differed between various
groups.
Phylogenetic Analysis
Eleven gene sequences of S. pneumoniae strains were used as a
single concatenated sequence of multiple genes for phylogenetic
analysis. The eleven gene sequences from each of the 72 strains
were concatenated in the following order: 16S rRNA, hemolysin-
related protein, hemolysin A-putative, hemolysin, DNA-directed
RNA polymerase – b subunit, cell wall surface anchor family
protein 2, cell wall surface anchor family protein 3, Antigen, cell
wall surface anchor family protein, pspA, cell wall surface anchor
family protein 1 and putative pneumococcal surface protein.
MrBayes program version 3.1.2 which uses Markov chain Monte
Carlo (MCMC) method to approximate the posterior probabilities
of trees generated from the aligned sequences [52,53], was used
with the following settings: F81 nucleotide substitution model,
equal rates variation across sites, transition/transversion ratio of 2
[Tratiopr = beta (2,1)]. The MCMC analysis was run for 100000
generations with chain sampled every 100
th generation resulting in
Table 4. Analysis of S. pneumoniae DNA sequence polymorphism using DnaSP program
{.
Group of
strains
Number
of strains
Number of
ST-complexes
or serotypes
Total Number
of Sites/Net
Sites
Total Number
of Mutations
(Eta)*
Number of
Segregating
Polymorphic
sites (S)*
Nucleotide
Diversity (p)*
Average Number
of Nucleotide
Differences (k)*
Mutation
Rate hG*
All - genes
a 72 21231/9791 71 (696) 66 (649) 0.0010 (0.0097) 9.74 (95.39) 14.67 (143.60)
Conserved -
genes
b
72 6704/5338 27 (146) 27 (145) 0.0005 (0.0028) 2.83 (15.09) 5.64 (30.12)
Variable -
genes
c
72 14465/4451 123 (547) 113 (503) 0.0040 (0.0179) 17.94 (79.86) 25.35 (112.86)
Number of
ST-complexes
Serotype 3
(and ST-180
complex)
a
18 1 20322/17816 31 (560) 31 (550) 0.0004 (0.0077) 7.66 (136.53) 9.14 (162.81)
Serotype 6B
a 8 6 20359/17814 66 (1169) 58 (1037) 0.0013 (0.0231) 23.13 (412.00) 25.31 (450.85)
Serotype 14
a 5 5 20034/13168 53 (695) 50 (663) 0.0020 (0.0268) 26.75 (352.20) 25.33 (333.60)
Serotype 19A
a 7 6 20406/13160 75 (983) 65 (852) 0.0021 (0.0279) 27.86 (366.62) 30.49 (401.22)
Serotype 19F
a 5 3 20186/16655 35 (586) 35 (582) 0.0010 (0.0166) 16.61 (276.60) 16.89 (281.28)
Serotype 23F
a 5 4 20078/17462 33 (576) 32 (559) 0.0009 (0.0152) 15.18 (265.10) 15.83 (276.48)
Number of
serotypes
ST180
(and
Serotype 3)
a
18 1 20322/17816 31 (560) 31 (550) 0.0004 (0.0077) 7.66 (136.53) 9.14 (162.81)
ST 81
a 5 3 20004/16770 5 (84) 5 (80) 0.0002 (0.0026) 2.61 (43.80) 2.40 (40.32)
ST 199
a 3 2 19861/18779 24 (443) 24 (442) 0.0008 (0.0157) 15.71 (295.00) 15.73 (295.33)
ST 377
a 4 4 19841/18797 7 (126) 7 (126) 0.0002 (0.0036) 3.57 (67.17) 3.66 (68.73)
ST 690
a 3 3 19591/19007 1 (11) 1 (11) 0.0000 (0.0004) 0.39 (7.33) 0.39 (7.33)
a: Sequences were concatenated in the order 16S rRNA, hemolysin-related protein, putative hemolysin A, hemolysin, DNA-directed RNA polymerase – beta subunit, cell
wall surface anchor family protein 1, cell wall surface anchor family protein 2, cell wall surface anchor family protein 3, antigen -cell wall surface anchor family protein,
pneumococcal surface protein A, putative pneumococcal surface protein.
b: Order of sequence concatenation for 5 conserved genes was 16S rRNA, hemolysin-related protein, putative hemolysin A, hemolysin, DNA-directed RNA polymerase –
beta subunit for the analysis.
c: Six variable gene sequences were concatenated in the order cell wall surface anchor family protein 1, cell wall surface anchor family protein 2, cell wall surface anchor
family protein 3, antigen -cell wall surface anchor family protein, pneumococcal surface protein A, putative pneumococcal surface protein. for the analysis.
*: Data normalized for net number of sites and expressed per 1000 bases. Raw values are shown in the parentheses.
{: Data generated using DnaSP program, version 5.1.
doi:10.1371/journal.pone.0015950.t004
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summarized after discarding 25% (2500) of the posterior sample.
The consensus tree is generated and displayed as either a
cladogram showing posterior probabilities for each split or a
phylogram with associated mean branch lengths.
Recombination Analysis
Recombination events among the pspA gene of the S. pneumoniae
strains were identified using recombination detection program
(RDP) package which incorporates RDP, GENECONV, Maxchi,
Chimaera, 3Seq, Bootscan and SiSscan programs [54] to predict
recombination signals from aligned DNA sequences. The recom-
bination events were scored as significant only if at least 4 out of 7
individual programs in the package identified the events with a P
value of #0.01. The recombinant sequences/events from pspA gene
of pneumococcal strains were further mapped to specific domains of
TIGR4 PspA (SP_0117) using the pspA gene accession numbers
AF071816 and M74122 [32,55] to determine the domain
coordinates for TIGR4 pspA sequence. The recombination events
in the pspA gene were divided by the following regions: signal
peptide sequence upstream of the gene (SP), the first ,100 residues
of the mature protein (A), the transition zone between A and B (A*),
the clade-defining region (B), and the proline-rich region (C).
Analysis of polymorphisms in gene sequences of
pneumococcal isolates
MUMmer tool (http://mummer.sourceforge.net/) was used to
detect substitutions, insertions and deletions (indels) in the gene
sequences of pneumococcal strains. Gene sequence from individ-
ual S. pneumoniae strains was compared to the corresponding
TIGR4 reference gene sequence using MUMmer. The location
and the size of polymorphism(s) were identified and grouped based
on their size. Strains showing both unique and common indels
(shared by more than one strain) were identified.
In silico identified deletions in pspA gene of strains belonging to
ST81-complex, ST180-complex, and ST199-complex were fur-
ther mapped to specific domains of TIGR4 pspA as described
above (for recombination events) and were represented on a linear
map using genomic visualization software Genvision version
2.0.0.29 (http://www.dnastar.com).
Results
Accuracy of the pneumococcal resequencing array
The selected genomic sequences (Table 3) were tiled on the
chip using S. pneumoniae TIGR4 genome sequence as a reference
genome as described in the Methods. TIGR4 is a clinical isolate
known to be highly invasive and virulent in a mouse model of
infection [56] and therefore makes an ideal reference genome for
collection of genomic diversity of other clinical pneumococcal
isolates. The fully determined genome sequences of pneumococcal
strains TIGR4, R6 and 670 were used to determine the
resequencing accuracy of the Affymetrix resequencing platform
[Figure S1 (upper panel)]. The overall accuracy of our
resequencing platform was 99.8%, corresponding to an average
Phred quality score of 27 [57].
We obtained 92 to 99% base call frequency of the conserved
genes (16S rRNA, hemolysin, putative hemolysin A, hemolysin-
related protein, DNA-directed RNA polymerase - beta subunit)
from 72 pneumococci, with the DNA-directed RNA polymerase –
b subunit showing the highest variability from among conserved
gene fragments. In contrast, the base call frequencies of the
variable genes (cell wall surface anchor family proteins 1–3, and
antigen, pneumococcal surface protein – putative, pspA) ranged
from 50 to 90% (Figure 1 upper panel). Table S4 summarizes
the validation results in terms of the expected SNPs to those
observed SNPs using the resequencing platform. The greatest
sequence identity between the TIGR4 reference sequence and the
query sequence was detected among the conserved genes; while
the SNP detection rate was lower in the variable genes, the overall
accuracy remained high in these fragments. A higher number of
false negatives, especially in variable cell wall surface family
proteins and pspA genomic regions can be attributed to the
sequence diversity together with the stringent filter parameters
used [44]. The lower panel in Figure 1 shows additional sequence
coverage ($95%) for the eleven pneumococcal genomic loci by
complementing the resequencing array platform with ABI Sanger
sequencing data. As expected, only a small (0.09% to 5.77%)
improvement in the sequence information of five conserved
housekeeping genes was achieved; in contrast, a significant
improvement was obtained in the variable gene sequences,
especially in the pspA gene where the sequence content increased
by almost 50%. TIGR4 shared .99% sequence identity with
AF071816, a PspA clade 3 serotype 4 strain (data not shown) [32].
Serotype and ST-complex designations of the 72 strains analyzed
are shown in Tables 1 & 2.
Phylogenetic analysis
The phylogenetic clustering of strains based on concatenated
genomic sequence information of all the 11 gene fragments is
shown in Figure 2. In general, the clustering correlated with the
ST-complex designation. For example, despite including strains
from multiple serotypes, ST690-complex strains clustered togeth-
er, and ST377-complex strains clustered together. Moreover, all
ST690-complex strains were PspA clade 1, with 81.7% sequence
identity with respect to a clade-defining region of clade 1 Genbank
sequence, AF071804. Likewise, all ST377-complex strains were
PspA clade 4, with 88.1–89.1% sequence identity in the clade-
defining region to a clade 4 Genbank sequence, AF071824.
Four unexpected clustering patterns were observed. In the first
case, two serotype 14 clones clustered together, but did not appear
to have related MLST designations. However, further analysis
revealed that the England
1429 clone (ST9) and the Slovakia
14210 clone (ST20) have 4 of 7 MLST alleles in common.
Moreover, both serotype 14 international clones belong to PspA
clade 1, and have identical pspA gene sequences. Therefore, their
close proximity in phylogenetic clustering is likely an accurate
representation of their genetic relatedness. In the remaining three
cases, a single MLST-defined clone was divided into two distinct
clusters in our tree. Among ST180-complex serotype 3 strains,
75% (3/4) of the strains from the latter part of the 2002 (PA318,
PA321, PA325) were grouped in a separate cluster. Among the
ST81-complex strains, one strain (PA26) did not cluster with the
remaining four strains (
23F-1, PA175, PA189, PA195). Likewise,
among ST199-complex strains, one strain (PA136) did not cluster
with the other two strains (PA52, PA223). Strains belonging to
both ST81- and ST199-complexes were associated with multiple
serotypes, but the clustering in our tree did not correlate with
specific serotypes serotype.
Further analyses revealed that the subclusters within an ST-
complex were due in part to a variation in the pspA gene. As seen
in Figure 3, some of the strains within an ST-complex had a
significantly different pattern of deletions throughout their pspA
gene sequence when compared to the remainder of the strains
within the specific ST-complex. Using the Genbank sequences to
analyze the clade-defining region [32], the marked variation that
was detected in the pspA gene sequence correlated with a different
clade designation. For example, unlike most of the ST180-
Pneumococcal Resequencing Array
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sequence analysis of the clade-defining region), three of the strains
collected in 2002 belonged to clade 1. Likewise, the ST81-complex
strains belonged to both clades 3 and 4, while ST199-complex
strains belonged to clades 1 and 4. Moreover, strains belonging to
ST81-complex and ST199-complex appeared to have undergone
recombination at both the capsular locus and within the pspA gene.
For example, PA26 is a serotype 19F variant of the Spain
23F-1
clone; however, this clone belongs to PspA clade 3, and PA26
belongs to a different PspA clade and family. Likewise, PA136 and
PA223 strains both belong to ST199-complex, but differ by
serotype and PspA clade/family classification (Figure 3).
SNP analysis
In an effort to ascertain whether the resequencing data could
accurately classify various groups of genes and strains, we
compared the total number of SNPs, degree of heterogeneity
using DnaSP, and frequency of recombination with the RDP
package. Table 5 shows the quantitative SNP profile of the
targeted genomic regions among pneumococcal isolates. The gene
sequences classified as ‘conserved’ had fewer SNPs compared to
the ‘variable’ gene sequences with one exception. The cell wall
surface anchor family protein 2 gene sequence had fewer SNPs
than the DNA-directed RNA polymerase, beta subunit. The pspA
gene was clearly the most polymorphic gene fragment among the
variable gene sequences; however, other less well-characterized
surface proteins were also quite genetically diverse. The cumula-
tive S. pneumoniae SNP profile for all the eleven gene fragments is
shown in Figure S2. Table 4 shows the results of the SNP
analysis based on the DnaSP program. The %GC content of the
sequences ranged from 42–48%. The nucleotide diversity (p) and
the mutation rate per sequence (hG) were 8-fold and 4.5-fold
higher respectively for the variable gene sequences compared to
the conserved sequences.
Figure1. Call rate perpneumococcalgenomic fragment. Theupperpanel showsthe resequencing profile of the elevengenomic fragments tiled
on the chip and analyzed from 72 strains in duplicates. The variability in call rate increases as the query sequence diverges from the reference on the
chip. The vertical bars represent the standard deviation in the results. The lower panel shows the complementation of sequence information using
complementary ABI Sanger sequencing method for the genomic fragments. Cumulative data obtained was $95% sequence information per fragment
(Table S2). Light blue bars: resequencing array platform; dark red bars: cumulative data from resequencing array and Sanger sequencing platforms.
doi:10.1371/journal.pone.0015950.g001
Pneumococcal Resequencing Array
PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e15950Figure 2. Phylogenetic clustering of pneumococcal strains using concatenated genomic sequences of all 11 genes. Genomic sequence
information of all the 11 gene fragments of 72 S. pneumoniae strains was used to generate the phylogenetic tree, and MrBayes program was used to
generate the consensus tree as described in Methods. The clustering was viewed and edited in TreeDyn http://www.treedyn.org/. The posterior
probability score of clusters at its node ranged from 0.5 to 1.0. The frequency of posterior probability score of 1.0 was 63% and only 20% of clusters
showed 0.5 as the posterior probability score at their nodes. Unexpected clusters of strains, based on MLST classifications, are indicated with shaded
backgrounds. A: ST-complex designation, B: serotype/serogroup designation.
doi:10.1371/journal.pone.0015950.g002
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PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e15950Figure 3. In silico mapping of pspA gene deletions to protein domains. Deletions in pspA gene identified in silico for S. pneumoniae strains
belonging to ST180, ST81 and ST199-complex were used for this analysis. Data for eighteen strains belonging to ST180 (upper panel), three strains
of ST81-complex (middle panel), and three strains of ST199-complex are shown (lower panel). Two strains of ST81-complex (PA195 and PA189)
were excluded because of low sequence coverage (Table S3). The nucleotide coordinates and protein domains of the pspA gene are shown at the
top of each panel. The thickness of the vertical line represents the size of the deletion. SP: signal peptide, A: ,first 100 residues of mature protein,
A*: transition zone between A and B, B: clade-defining region, C: proline rich (PR) and non-proline rich (NPR) regions, CB: choline binding domain.
doi:10.1371/journal.pone.0015950.g003
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serotype-specific and ST-complex-specific analyses. All serotype 3
strains belonged to one ST180-complex; in contrast strains from
other common serotypes each included strains belonging to 3–6
different ST-complexes. Likewise, the ST180-complex was
comprised of only serotype 3 strains; in contrast, other ST-
complexes were comprised of strains from 2–4 different serotypes.
We compared serotype3/ST180-complex strains to other sero-
types and ST-complexes that included $3 strains, namely ST81,
ST180, ST199, ST377, and ST690 (Table 1).
Compared to the serotype 3 strains, the nucleotide diversity (p)
and mutation rate per sequence (hG) were $2-fold higher for
serotypes 6B, 14, 19A, 19F, and 23F strains. For example, serotype
3 strains had a nucleotide diversity (p) of 0.0004, and mutation
rate per sequence (hG) of 9.14. Strains from serotypes 6B, 14, 19A,
19F, and 23F had nucleotide diversity values (p) ranging between
0.009–0.021, and mutation rates per sequence (hG) ranging
between 15.83–30.49. In essence, serotypes associated with more
than one ST complex had a larger degree of sequence
polymorphism than a serotype associated with one ST complex
(Table 4).
In general, less sequence polymorphism was detected among
strains of the same ST-complex compared to strains of the same
serotype (Table 4). This association was often true even when
strains belonging to the same ST-complex were of different
serotypes. For example, ST180-complex strains, consisting of only
serotype 3 strains, had 20-fold higher mutation rate than ST690-
complex strains, which included strains from serotypes 6A, 19A,
and nontypeable (NT) serotypes. One key exception was ST199-
complex, consisting of serogroup 15 and serotype 19A strains. The
ST199-complex strains were significantly more genetically diverse
than the strains belonging to other ST-complexes.
Recombination analysis of the pspA gene
As shown in Figure 4, 31 recombination events in the pspA
gene were detected in the 72 strains using the RDP package. The
recombination events spanned from 1–3 domains of the pspA gene
with 32.3% (10/31) of the events including the clade-defining
region, 35.5% (11/31) of the events including the proline-rich
region, and 48.4% (15/31) spanning both domains. Strains
belonging to ST-complexes containing $3 strains were commonly
associated with recombination events in the pspA gene. In general,
recombination events that included the clade-defining region
correlated with the PspA designation of those strains. For example,
given that strains from ST81-complex, ST180-complex, and
ST199-complex belonged to multiple PspA clades, not all of the
strains belonging to these ST-complexes would be expected to be
implicated in a clade-specific recombination event. The one
exception was a recombination event in the clade-defining region
that included both PspA clade 3 and clade 4 strains belonging
ST81-complex. One other recombination event included both
PspA clade 3 and clade 4 strains belonging to the ST81-complex;
however, this recombination event spanned the non-proline rich
region and the choline binding domain rather than the clade-
defining region.
Discussion
The licensure of the PCV7 vaccine resulted in a marked decline
in invasive pneumococcal disease [58], and further reductions are
anticipated with the introduction of PCV13. However, since both
of these vaccines are serotype-dependent, serotype replacement
remains a major concern. For example, non-PCV7 variants of the
PCV7 international clones, such as the 19A variant of the Taiwan
19F-14 clone, have expanded since introduction of the PCV7
vaccine. Thus the international clones, which by definition are
widely disseminated, can evade a conjugate vaccine by capsular
transformation. While MLST is a powerful method to establish the
genetic relatedness of strains over long periods of time, this method
cannot discriminate between highly-related strains of different
serotypes or different PspA clades. Variable loci have been
suggested to provide higher discrimination than MLST and
therefore be more appropriate for local epidemiology and clinical
settings [10,59]. Studies have also been reported where antigen or
surface-associated gene sequences have been used with MLST
data to infer local epidemiology [36,60,61] In this study, we
assessed the accuracy of a targeted Affymetrix, Inc. GeneChipH
resequencing array for five conserved and six variable genes that
encoded conserved proteins, such as hemolysins, and variable
surface proteins, including the pspA gene. After supplementing the
array with Sanger sequencing of diverse regions, the 11
Table 5. Quantitative SNP profile of targeted genomic regions among pneumococcal strains.
Name/Locus
Gene
Classification Gene/Sequence Length (bp)
No. of
strains
{
Total
SNPs SNPs/Kb/strain Fold difference*
16S_rRNA Conserved 16S rRNA 1413 72 124 1.22 1.00
SP_0834 Hemolysin-related protein 510 72 393 10.70 8.78
SP_1204 Hemolysin A - putative 594 72 165 3.86 3.17
SP_1466 Hemoylsin 645 72 115 2.48 2.03
SP_1961 DNA-directed RNA polymerase, beta subunit 3609 72 1344 5.17 4.24
SP_0368 Variable Cell wall surface anchor family protein 1 5301 69 6862 18.76 15.39
SP_1833 Cell wall surface anchor family protein 2 2124 71 598 3.97 3.26
SP_1992 Cell wall surface anchor family protein 3 663 72 331 6.93 5.69
SP_2145 Antigen, cell wall surface anchor family 2082 72 2733 18.23 14.96
SP_0667 Pneumococcal surface protein - putative 996 69 798 11.61 9.53
SP_0117 pspA
6 2232 68 15240 100.41 82.38
{strains with $95% sequence coverage.
*compared to 16S rRNA.
6pneumococcal surface protein A.
doi:10.1371/journal.pone.0015950.t005
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and compared to the MLST-defined clones to determine if this
approach could further discriminate between genetically related
strains. Our resequencing array design based only on a single
pneumococcal genome (TIGR4) required supplementation of
sequencing efforts, especially in the variable gene sequences.
Future resequencing array design based on genomic sequence
information from a large number of variable gene sequences
available in Genbank is likely to eliminate or significantly reduce
the need for the complementary Sanger sequencing approach.
Moreover, we demonstrated that DnaSP and RDP could
accurately identify SNPs and recombination events respectively
suggesting, this method could be customized for any set of gene
sequences to quickly characterize novel genes and monitor the
pneumococcus for ‘vaccine escape’ strains.
The resequencing accuracy of the Affymetrix platform ranged
from 92–99% for the conserved gene sequences. As expected, the
array could not accurately sequence diverse regions of the variable
genes, such as the pspA gene; however, the conserved portion of
diverse genes could be used to design primers, thereby decreasing
the sequencing effort to some degree. In general, the phylogenetic
analysis of the 11 concatenated gene sequences created clusters
that correlated with the ST-complex designations. On three
occasions, an MLST-defined clone was divided into two separate
clusters, or subclusters, using the dual platform method. Further
analyses revealed that each of the subclusters consisted of a group
of strains belonging to the same ST-complex and identical PspA
clade designation.
It would be ideal if all strains belonging to a single MLST-
defined clone could be targeted by a PspA vaccine. However, these
data suggest that commonly-occurring clones include strains from
multiple PspA clades and families. Therefore, a PspA vaccine
which preferentially protects against one PspA family may be
unable to prevent infections due to all strains belonging to a single
clone. Specifically, strains belonging to two different PspA clades,
and even families, were detected within strains belonging to the
Spain
23F-1 clone, and clones associated with serotype 3, 15B/C,
and 19A strains in the post-PCV7 era [62]. While limited by the
small numbers of strains, it is possible that a ST180-complex clone
was expanding at the latter part of the study with a different PspA
clade, as most of the 2002 strains belonging to this ST-complex
were of PspA clade 1 rather than PspA clade 3. In some cases,
Figure 4. Recombination events detected in the pspA gene of 72 strains using the recombination detection package. Two
recombination events are not shown in the figure as they could not be mapped to the corresponding TIGR4 PspA sequence. One of these events was
detected only in one strain PA179 with nucleotide coordinates 178 to 389. The second event with coordinates 1128 to 1178 was detected in five
strains. Two strains of ST81-complex (PA195 and PA189) were excluded because of low sequence coverage (Table S3). The nucleotide coordinates
and protein domains of the pspA gene are shown at the top and bottom of the figure.
a Number (percent) of 72 strains with this recombination event.
b Among ST-complexes that included $3 strains: percent of strains belonging to specific ST-complex with recombination event, PspA clade
designation(s).
c SP: signal peptide, A: ,first 100 residues of mature protein, A*: transition zone between A and B, B: clade-defining region, C: proline
rich (PR) and non-proline rich (NPR) regions, CB: choline binding domain.
doi:10.1371/journal.pone.0015950.g004
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pspA gene were detected in a single strain belonging to a common
clone, underscoring the pneumococcus’ ability to potentially evade
both PCV13 and a PspA vaccine. For example, a child immunized
with PCV7, PCV13, and a PspA vaccine containing family 1
(clades 1–3) antigens, could potentially still develop IPD upon
exposure to a strain belonging to ST199-complex as this strain is a
serogroup 15 strain with PspA clade 4.
In this study, we also sought to determine whether the
combined approach of resequencing array complemented with
standard sequencing could be used to characterize novel genes and
monitor for ‘vaccine escape’ strains through mutations and
recombination events. The sequence polymorphism analysis
program, DnaSP, confirmed that substantially fewer SNPs were
detected in most of the conserved genes compared to the variable
genes, with the hG value an excellent marker of genetic diversity.
Moreover, the DnaSP program usually detected greater sequence
diversity among strains of a given serotype than strains of a given
ST-complex. Finally, most of the serotypes which included strains
that belonged to multiple ST-complexes had higher sequence
heterogeneity than serotypes which included strains belonging to a
single ST-complex. As reported previously [32], the RDP data
demonstrated that the pspA gene had undergone extensive
recombination, and the size of the recombination event could
span one or multiple protein domains. Individual recombination
events varied in frequency of occurrence, ranging from 1–35%.
Moreover, strains from ST-complexes including at least 3 strains
were commonly implicated. In general, recombination in the
clade-defining region correlated with PspA designation, suggesting
that these recombination events were accurately identified.
Approximately 50% of the recombination events spanned either
the clade-defining region or the proline-rich block. Since these two
regions are targeted in most of the pspA vaccine studies, these data
suggest that recombination events in this region could potentially
allow the pneumococcus to evade a pspA-based vaccine. Taken
together, the DnaSP and RDP programs are robust and can be
used to characterize novel genes and vaccine-candidate genes from
a large number of strains that were analyzed.
In summary, this pneumococcal resequencing array accurately
and efficiently resequenced conserved sequences. The resequen-
cing of the variable sequences on the array was comparatively less
efficient than the conserved ones; however, the array enabled
efficient primer design for the diverse regions, which were
subsequently sequenced by an alternate method. Moreover, the
phylogenetic analysis both correlated with MLST and detected
strains within a single clone that belonged to multiple PspA clades
and families. In addition, the array accurately identified both
SNPs and recombination events using the DnaSP and RDP
programs, respectively.
Future resequencing array designs could include gene sequences
from a large number of available S. pneumoniae genomes rather
than just one genome (TIGR4). By exploiting the large number of
available S. pneumoniae genomes one could design a comprehensive
molecular subtyping tool that does not require a complementary
sequencing approach. While there are a plethora of potential
pneumococcal targets for future arrays, the inclusion of MLST
gene sequences in addition to diverse gene sequences would allow
the strain to be simultaneously subtyped by MLST while
characterizing clinically-important and biologically-relevant genes.
In the future, the resequencing array may become an indispens-
able molecular subtyping method which can accurately determine
the role of recombination and polymorphisms in the evolution of
bacteria, such as S. pneumoniae, in response to vaccine pressure or
antibiotic use.
Supporting Information
Figure S1 Resequencing accuracy of S. pneumoniae
genomic fragments. The resequencing accuracy was deter-
mined based on the fully sequenced R6 and 670 genomes. The
upper panel represents the accuracy of the calls and the lower
panel shows the filtered call rates of the fragments for R6 and 670
strains. Call rate is defined as the fraction of total queried bases
that can be clearly detected and identified or ‘‘called’’ by the
algorithm. The accuracy was higher for 670 sequences compared
to R6 genomic fragments. The resequencing accuracy for R6 was
found to be 100% for 8 fragments which included all the
conserved genes, cell wall surface anchor family proteins 2 and 3
as well as pneumococcal putative surface protein among variable
sequences. The resequencing accuracy for two other variable
genes cell wall surface anchor family protein 1 and antigen, cell
wall surface anchor protein was $99.9%. Pneumococcal surface
protein A having an accuracy of 97.1%. The resequencing
accuracy for the 670 genomic fragments ranged from 98.6 to
100% with nine fragments having 100% accuracy. The resequen-
cing accuracy for two variable genes cell wall surface anchor
family protein 1 and pneumococcal surface protein A was $99.9%
and 98.6% respectively. There are differences in the call rates of
the two strains indicating sequence diversity as shown in the lower
panel. The pneumococcal putative surface protein (SP_0667) had
significantly lower call rate in 670 compared to R6.
(TIF)
Figure S2 Single nucleotide polymorphisms per S.
pneumoniae genomic fragment. The number of SNPs per
genomic fragment were obtained from the sequence data
generated using resequencing array (light blue bars) in duplicates
and complemented with Sanger sequencing (dark red bars) from
all 72 strains (Table S1). The validation of resequencing array
based SNP detection was done using fully determined genome
sequences of TIGR4, R6 and 670 strains (Table S4).
(TIF)
Table S1 Gene sequences of pneumococcal strains
(re)sequenced in this study.
(DOC)
Table S2 List of primers used for expansion of
sequence coverage.
(DOC)
Table S3 Gene loci and strains with ,95% sequence
coverage.
(DOC)
Table S4 Validation of resequencing array based on
ability to detect SNPs.
(DOC)
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